## Abstract A realโtime polymerase chain reaction assay for quantitation of EpsteinโBarr virus (EBV) DNA in serum was developed. This assay detected EBV DNA in 24 (89%) of 27 sera from patients with infectious mononucleosis, but only in 9 (18%) of 51 sera from EBV carriers (__P__โ<โ0.001) and in no
The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers
โ Scribed by Paolo De Paoli; Chiara Pratesi; Maria Teresa Bortolin
- Book ID
- 106123754
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 283 KB
- Volume
- 133
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Two human lymphoblastoid cell lines were established by the transformation of human cordโblood lymphocytes with transforming EpsteinโBarr virus (EBV). One cell line (HLBโR1) was established with EBV obtained after the superinfection of Raji cells with HRโ1 EBV and the other (HLBโB1) was
## Abstract ## BACKGROUND Serologic measurement of antibodies to EpsteinโBarr virus (EBV) immunoglobulin A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to screen for nasopharyngeal carcinoma (NPC) in China. Recently, it was found that plasma EBV DNA concentration
DNA from malignant cells is present in the serum/plasma of cancer patients and DNA from this source is amenable to analysis by polymerase chain reaction (PCR). In the present study, we evaluated whether Epstein-Barr virus (EBV) DNA is present in the serum of patients with EBV-associated Hodgkin's di